SCHEMBL5086253

SCHEMBL5086253

CNC(=O)C1CCC(c2ncc3c(N)nc(-c4ccc5ccc(Oc6ccccc6)nc5c4)cn23)CC1

nearest known ligand 0.50

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TNK2 Q07912 11/20 0.50
IGF1R P08069 6/20 0.43
ABL1 P00519 2/20 0.36
KLKB1 P03952 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5084882 0.91 IGF1R (0.48) TNK2IGF1R
SCHEMBL5083787 0.85 TNK2 (0.42) TNK2IGF1RABL1
SCHEMBL5086076 0.85 IGF1R (0.44) TNK2IGF1RABL1
SCHEMBL5081320 0.83 TNK2 (0.44) TNK2IGF1R
SCHEMBL5082567 0.83 IGF1R (0.44) TNK2IGF1R
SCHEMBL5086140 0.81 TNK2 (0.45) TNK2IGF1R
SCHEMBL4073244 0.80 IGF1R (0.51) TNK2IGF1R
SCHEMBL397651 0.79 TNK2 (0.78) TNK2IGF1R
SCHEMBL5081252 0.79 TNK2 (0.42) TNK2IGF1RABL1KLKB1
SCHEMBL396775 0.77 TNK2 (0.65) TNK2IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008076143-A1 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2008-06-26 WO claimed